Board Meeting11 Aug 2026, 05:12 pm
Beryl Drugs Board Approves Unaudited Financial Results for Q1 FY27
AI Summary
Beryl Drugs Ltd held its Board of Directors meeting on August 11, 2026. The board considered and approved the unaudited financial results for the quarter ended June 30, 2026. Additionally, the Limited Review Report from the auditors for these financial results was taken on record. The company also confirmed the registered office location.
Key Highlights
- Board meeting held on August 11, 2026.
- Unaudited financial results for Q1 FY27 approved.
- Limited Review Report from auditors taken on record.
- Registered office location confirmed.
Price Impact
More from BERLDRG